AbbVie Inc., turned a blind eye on cardiovascular risks associated with its AndroGel testosterone replacement therapy, said the attorney for a man suing the company over claims that AndroGel caused a blood clot to develop deep in his veins. The only warning Robert Rowley had that his testosterone treatment could cause heart attacks, strokes and blood clots was a warning on the product’s safety label about an increased risk for polycythemia, a blood thickening disease that can lead to blood clots. “But it’s not the only way,” Rowley’s attorney told an Illinois federal jury during the latest bellwether trial in ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.